Mostrando 8 resultados de: 8
Filtros aplicados
Subtipo de publicación
Article(8)
Publisher
Science(2)
Cell Reports Methods(1)
Frontiers in Immunology(1)
Infection, Genetics and Evolution(1)
Leukemia(1)
Área temáticas
Enfermedades(5)
Farmacología y terapéutica(5)
Medicina forense; incidencia de enfermedades(3)
Microorganismos, hongos y algas(3)
Medicina y salud(1)
Origen
google(1)
Antibody decay, T cell immunity and breakthrough infections following two SARS-CoV-2 vaccine doses in inflammatory bowel disease patients treated with infliximab and vedolizumab
ArticleAbstract: Anti tumour necrosis factor (anti-TNF) drugs increase the risk of serious respiratory infection andPalabras claves:Autores:Ahmad T., Ahmed M., Alexander J.L., Altmann D.M., Appleby R., Avanzi L., Barbutti I., Barr S., Bewshea C., Bi R., Bokth F., Bourges C., Boyton R.J., Brown M., Bull R., Butler D.K., Carungcong J., Chambers N., Chanchlani N., Chee D., Cipriano B., Clayton S., Constable L., Costa P., Cotter C., Cottrill C., Cousins H., Davey L., Dawe C., Dawson J., Diana Mūnoz Sandoval, Finlayson L., Francia C., Fraser W., George V., Goodhand J.R., Gozzard M.E., Grove J., Haigh A., Hannington H., Hart A.L., Hendy P., Hong K., Howman R., Hull R., Irving P.M., Janjua M., Johnson E., Jones G.R., Kapizioni C., Kennedy N.A., Khalid N., Khatun H., Kingston A., Kirkineziadis N., Kok K.B., Kontos C., Kottoor S.H., Lamb C.A., Lee I., Lee J.C., Lees C.W., Lehmann A., Lin K.M., Lin S., Manning J., Martins C., Matapure L., McDonald T.J., Mitchell M., Muhammed R., Murray C.D., Naik K., Nice R., Nundlall K., Pabriaga E., Phillis K., Pieper F.P., Plaatjies N., Powell N., Raine T., Reynolds C.J., Robinson M., Roebuck A., Rooney M., Saich R., Saifuddin A., Samuels K., Sebastian S., Seoane R.C., Silva N., Singh S., Sonwalkar S., Strongili K., Sultan S., Thomas R., Thompson T., Tilley B., White B.Fuentes:scopusCOVID-19 vaccine boosted immunity against Omicron in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors
ArticleAbstract:Palabras claves:Autores:Altmann D.M., Apperley J.F., Boyton R.J., Claudiani S., Diana Mūnoz Sandoval, Gibbons J.M., Innes A.J., Liu S., Loaiza S., McKnight Á., Milojkovic D., Pade C., Palanicawander R., Pieper F.P., Reynolds C.J.Fuentes:scopusHeterologous infection and vaccination shapes immunity against SARS-CoV-2 variants
ArticleAbstract: The impact of the initial severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infecting strPalabras claves:Autores:Altmann D.M., Boyton R.J., Brooks T.J.G., Butler D.K., Cutino-Mogue T., Diana Mūnoz Sandoval, Fontana M., Gibbons J.M., Joy G., Kele B., Lin K.M., Liu S., Maini M.K., Manisty C., McKnight Á., Menacho K., Moon J.C., Noursadeghi M., Otter A.D., Pade C., Pieper F.P., Reynolds C.J., Semper A.E., Smit A., Treibel T.A.Fuentes:scopusMapping immune variation and var gene switching in naive hosts infected with plasmodium falciparum
ArticleAbstract: Falciparum malaria is clinically heterogeneous and the relative contribution of parasite and host inPalabras claves:Autores:Barrett M., Berriman M., Diana Mūnoz Sandoval, Draper S.J., Edwards N.J., Hill A.V.S., Ivens A., Lotkowska M.E., Milne K., Minassian A.M., Nahrendorf W., O’toole A., Payne R.O., Regnault C., Reid A.J., Rowe J.A., Sanders M.J., Sankaranarayanan G., Silk S.E., Spence P.J., Venkatraman N.Fuentes:scopusIdentification of human leukocyte antigen in precancerous and cancerous cervical lesions from Ecuadorian women
ArticleAbstract: Cervical cancer is the fourth most common type of cancer in women. Worldwide, it is a public healthPalabras claves:Cervical Cancer, CIN, ECUADOR, HLA, HpvAutores:Calle P., Cruz C., Diana Mūnoz Sandoval, Galarza J.M., Guerra S., Lorena Mejía Castañeda, María José Mora, Rosa de los Ángeles Bayas-Rea, SONIA ZAPATA MENAFuentes:googlescopusImmune boosting by B.1.1.529 (Omicron) depends on previous SARS-CoV-2 exposure
ArticleAbstract: The Omicron, or Pango lineage B.1.1.529, variant of severe acute respiratory syndrome coronavirus 2Palabras claves:Autores:Abbass H., Abiodun A., Alfarih M., Alldis Z., Altmann D.M., Amin O.E., Andiapen M., Artico J., Augusto J.B., Baca G.L., Bailey S.N.L., Bhuva A.N., Boulter A., Bowles R., Boyton R.J., Bracken O.V., Brooks T.J.G., Bullock N., Butler D.K., Captur G., Carr O., Champion N., Chan C., Chandran A., Coleman T., Couto-Parada X., Cross E., Cutino-Moguel T., D'Arcangelo S., Davies R.H., de Sousa J.C., Di Genova C., Diana Mūnoz Sandoval, Dieobi-Anene K., Diniz M.O., Douglas B., Ellis A., Feehan K., Finlay M., Fontana M., Forooghi N., Francis S., Gibbons J.M., Gillespie D., Gilroy D., Hamblin M., Harker G., Hemingway G., Hewson J., Heywood W., Hickling L.M., Hicks B., Hingorani A.D., Howes L., Itua I., Jardim V., Jensen M., Jones J., Jones M., Joy G., Kapil V., Kelly C., Kurdi H., Lambourne J., Lee W.Y.J., Lin K.M., Liu S., Lloyd A., Louth S., Maini M.K., Mandadapu V., Manisty C., McKnight Á., Menacho K., Mfuko C., Mills K., Millward S., Mitchelmore O., Moon C., Moon J., Moon J.C., Murray S.M., Noursadeghi M., O'Brien B., Otter A.D., Pade C., Palma S., Parker R., Patel K., Pawarova M., Petersen S.E., Pieper F.P., Piniera B., Rannigan L., Rapala A., Reynolds C.J., Richards A., Robathan M., Semper A.E., Treibel T.A.Fuentes:scopusQuantitative, multiplexed, targeted proteomics for ascertaining variant specific SARS-CoV-2 antibody response
ArticleAbstract: Determining the protection an individual has to severe acute respiratory syndrome coronavirus-2 (SARPalabras claves:complement: immunoglobulin, covid-19, Delta variant, Mass spectrometry, omicron variant, proteomics, SARS-COV-2, Vaccination, variant of concernAutores:Abbass H., Abiodun A., Áine McKnight , Alfarih M., Alldis Z., Altmann D.M., Amin O.E., Andiapen M., Artico J., Augusto J.B., Baca G.L., Bailey S.N.L., Baldwin T., Bhuva A.N., Boulter A., Bowles R., Boyton R.J., Bracken O.V., Brooks T.J.G., Bullock N., Butler D.K., Captur G., Carr O., Champion N., Chan C., Chandran A., Coleman T., Couto de Sousa J., Couto-Parada X., Cross E., Cutino-Moguel T., D'Arcangelo S., Davies R.H., Di Genova C., Diana Mūnoz Sandoval, Dieobi-Anene K., Diniz M.O., Douglas B., Doykov I., Ellis A., Feehan K., Finlay M., Fontana M., Forooghi N., Francis S., Gibbons J.M., Gillespie D., Gilmour K.C., Gilroy D., Hamblin M., Harker G., Hemingway G., Hewson J., Hickling L.M., Hicks B., Hingorani A.D., Howes L., Itua I., Jardim V., Jensen M., Jones J., Jones M., Joy G., Kapil V., Kelly C., Kurdi H., Lambourne J., Lee W.Y.J., Lin K.M., Liu S., Lloyd A., Louth S., Maini M.K., Mandadapu V., Manisty C., McKnight Á., Menacho K., Mfuko C., Mills K., Millward S., Mitchelmore O., Moon C., Moon J.C., Murray S.M., Noursadeghi M., O'Brien B., Otter A.D., Pade C., Palma S., Parker R., Patel K., Pawarova M., Petersen S.E., Pieper F.P., Piniera B., Rannigan L., Reynolds C.J., Semper A.E., Spiewak J., Treibel T.A.Fuentes:scopusRepeat controlled human malaria infection of healthy UK adults with blood-stage Plasmodium falciparum: Safety and parasite growth dynamics
ArticleAbstract: In endemic settings it is known that natural malaria immunity is gradually acquired following repeatPalabras claves:controlled human malaria infection (CHMI), human challenge model, MALARIA, malaria immunology, Plasmodium falciparumAutores:Bach F.A., Baker M., Barrett J.R., Cho J.S., Diana Mūnoz Sandoval, Draper S.J., Edwards N.J., Ellis K.J., Folegatti P.M., Hou M.M., Khozoee B., Lawrie A.M., Minassian A.M., Mitton C.H., Nahrendorf W., Nielsen C.M., Nugent F.L., Payne R.O., Poulton I.D., Quinkert D., Ramon R.L., Ramos-Lopez F., Rawlinson T.A., Salkeld J., Silk S.E., Spence P.J., Themistocleous Y.Fuentes:scopus